Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. (Q48610854)
Jump to navigation
Jump to search
scientific article published in December 1991
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. |
scientific article published in December 1991 |
Statements
1 reference
Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. (English)
1 reference
Rasmussen K
1 reference
Stockton ME
1 reference
Czachura JF
1 reference
Howbert JJ
1 reference
1 December 1991
1 reference
209
1 reference
1-2
1 reference
135-138
1 reference